NM_152743.4:c.354C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_152743.4(BRAT1):c.354C>T(p.Thr118Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,568,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00012 ( 0 hom. )
Consequence
BRAT1
NM_152743.4 synonymous
NM_152743.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.39
Publications
0 publications found
Genes affected
BRAT1 (HGNC:21701): (BRCA1 associated ATM activator 1) The protein encoded by this ubiquitously expressed gene interacts with the tumor suppressing BRCA1 (breast cancer 1) protein and and the ATM (ataxia telangiectasia mutated) protein. ATM is thought to be a master controller of cell cycle checkpoint signalling pathways that are required for cellular responses to DNA damage such as double-strand breaks that are induced by ionizing radiation and complexes with BRCA1 in the multi-protein complex BASC (BRAC1-associated genome surveillance complex). The protein encoded by this gene is thought to play a role in the DNA damage pathway regulated by BRCA1 and ATM. [provided by RefSeq, Mar 2012]
BRAT1 Gene-Disease associations (from GenCC):
- neonatal-onset encephalopathy with rigidity and seizuresInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with cerebellar atrophy and with or without seizuresInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 7-2544985-G-A is Benign according to our data. Variant chr7-2544985-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 540193.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.39 with no splicing effect.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BRAT1 | ENST00000340611.9 | c.354C>T | p.Thr118Thr | synonymous_variant | Exon 4 of 14 | 1 | NM_152743.4 | ENSP00000339637.4 | ||
| BRAT1 | ENST00000467558.5 | n.370C>T | non_coding_transcript_exon_variant | Exon 3 of 10 | 5 | |||||
| BRAT1 | ENST00000469750.5 | n.578C>T | non_coding_transcript_exon_variant | Exon 4 of 11 | 2 | |||||
| BRAT1 | ENST00000421712.1 | n.283-1023C>T | intron_variant | Intron 2 of 4 | 3 | ENSP00000409209.2 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152184Hom.: 0 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
20
AN:
152184
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000104 AC: 19AN: 183354 AF XY: 0.000111 show subpopulations
GnomAD2 exomes
AF:
AC:
19
AN:
183354
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000125 AC: 177AN: 1416316Hom.: 0 Cov.: 31 AF XY: 0.000127 AC XY: 89AN XY: 699934 show subpopulations
GnomAD4 exome
AF:
AC:
177
AN:
1416316
Hom.:
Cov.:
31
AF XY:
AC XY:
89
AN XY:
699934
show subpopulations
African (AFR)
AF:
AC:
0
AN:
32610
American (AMR)
AF:
AC:
0
AN:
37528
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
24886
East Asian (EAS)
AF:
AC:
1
AN:
37694
South Asian (SAS)
AF:
AC:
3
AN:
80610
European-Finnish (FIN)
AF:
AC:
1
AN:
49646
Middle Eastern (MID)
AF:
AC:
0
AN:
5660
European-Non Finnish (NFE)
AF:
AC:
169
AN:
1089018
Other (OTH)
AF:
AC:
3
AN:
58664
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000131 AC: 20AN: 152302Hom.: 0 Cov.: 30 AF XY: 0.0000940 AC XY: 7AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
20
AN:
152302
Hom.:
Cov.:
30
AF XY:
AC XY:
7
AN XY:
74472
show subpopulations
African (AFR)
AF:
AC:
1
AN:
41556
American (AMR)
AF:
AC:
1
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
17
AN:
68020
Other (OTH)
AF:
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
BRAT1: BP4, BP7 -
Dec 14, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Neonatal-onset encephalopathy with rigidity and seizures Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.